|
FRMD8 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.31099999967077E-07 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.38549999753701E-08 |
| Normal-vs-Stage2 |
8.663400E-03 |
| Normal-vs-Stage3 |
1.442440E-02 |
| Normal-vs-Stage4 |
2.127500E-02 |
| Stage1-vs-Stage2 |
8.098400E-01 |
| Stage1-vs-Stage3 |
3.506000E-02 |
| Stage1-vs-Stage4 |
2.812400E-01 |
| Stage2-vs-Stage3 |
2.631000E-01 |
| Stage2-vs-Stage4 |
5.673400E-01 |
| Stage3-vs-Stage4 |
6.448600E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
3.30260000014349E-07 |
| Normal-vs-AfricanAmerican |
1.332430E-02 |
| Normal-vs-Asian |
1.682350E-02 |
| Caucasian-vs-AfricanAmerican |
6.993200E-01 |
| Caucasian-vs-Asian |
5.456600E-01 |
| AfricanAmerican-vs-Asian |
4.567800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.05500000000281E-05 |
| Normal-vs-Female |
6.40400000029295E-07 |
| Male-vs-Female |
6.175800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.85859999612958E-08 |
| Normal-vs-Age(41-60Yrs) |
4.43279999999824E-05 |
| Normal-vs-Age(61-80Yrs) |
2.183600E-02 |
| Normal-vs-Age(81-100Yrs) |
1.715210E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.348000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.569720E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.974200E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
2.655000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
6.168800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.318000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.910090E-02 |
| Classical-VS-Follicular |
3.462700E-03 |
| Classical-VS-Other |
2.119600E-01 |
| Classical-VS-Normal |
6.93269996965284E-10 |
| Tall-VS-Follicular |
6.291200E-01 |
| Tall-VS-Other |
9.573200E-01 |
| Tall-VS-Normal |
3.643200E-01 |
| Follicular-VS-Other |
7.536400E-01 |
| Follicular-VS-Normal |
4.859900E-02 |
| Other-VS-Normal |
7.352000E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.24079999999738E-05 |
| Normal-vs-N1 |
8.801700E-02 |
| N0-vs-N1 |
2.841800E-01 |
|
|
